Factors of relevance described in the literature in DM include advanced glycated end-product deposition in the myocardium [3], myofibroblast ‘switching’ [14], autonomic neuropathy [12], inflammation via TNF-alpha and IL-1b [43], renin–angiotensin system activation [7], and blood glucose levels. This evidence concerns the gene REN and autonomic neuropathy.